|
Match
|
Document |
Document Title |
|
|
7048906 |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia,...
|
|
|
7045150 |
Tellurium containing nutrient formulation and process for enhancing the cumulative weight gain or feed efficacy in poultry
A novel nutrient formulation containing tellurium for use in poultry, and a method of feeding it which improves subsequent livability, cumulative feed efficacy or weight gain is disclosed.
|
|
|
7045143 |
Fat blend
The invention relates to an oil, fat and/or lecithin-based fat blend containing polyunsaturated fatty acids. The inventive fat blend is characterized in that the fatty acids gamma-linolenic,...
|
|
|
7041322 |
Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent
A phenolic fraction of fruit obtained from the Rosaceae family and also to the process for the specific extraction of this fraction. The phenolic fraction is rich in dihydrochalcones (phloridzin...
|
|
|
7041311 |
Preparation for saliva flow
The present invention is directed to products that promote saliva generation in the mouth through the use of various food grade acceptable acids. The products that enhance saliva production are...
|
|
|
7033582 |
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof,...
|
|
|
7029692 |
Transdermal therapeutic system with nicotine and addition of monoterpene ketones
A transdermal therapeutic system having a backing layer, at least one nicotine-containing layer ore zone, which may have pressure-sensitive properties, as well as a removable protective layer is...
|
|
|
7025985 |
Dihydroxyphenyl compounds and glucoside compounds thereof
The present invention is a compound represented by the following formula (1) or (2):
where one of R 1 and R 2 is hydrogen and the other one is hydrogen or glucose residue. The compound is...
|
|
|
7025965 |
Method of use and dosage composition of bluegreen algae extract for inflammation in animals
A means and method for treating inflammation and pain in animals is described. The compounds include phycocyanin in a pharmaceutically acceptable carrier. Phycocyanin has been found to be a COX-2...
|
|
|
7025984 |
Compositions and methods for body weight management
The present invention is for compositions and methods for managing the body weight of a subject using said compositions. Weight management, particularly weight gain and loss, is effectuated by...
|
|
|
7025992 |
Pharmaceutical formulations
The invention relates to pharmaceutical formulations for use in the administration of lipophilic medicaments via mucosal surfaces. In particular the invention provides pharmaceutical formulations...
|
|
|
7022349 |
Antihistamine composition
An extraction process and composition produced thereby for use as an antihistamine is disclosed. The composition comprises an extraction of Loranthus , which is derived from a species of ...
|
|
|
7022683 |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
The inventions disclosed herein relate to compositions for the sustained release of pharmacological agents comprising pectins having a combination of both a high molecular weight and a low degree...
|
|
|
7014865 |
Natural formulation for the treatment and prevention of depression, containing St. John's Wort and derivatives of dihydro- and tetrahydrofolic acid
The present invention relates to novel compositions containing a combination of the plant St. John's Wort ( Hypericum perforatum L.), its extracts of active ingredients and derivatives of dihydro-...
|
|
|
7014862 |
Chewable compositions containing a gel-forming extract of psyllium
Oral compositions, suitable for chewing, comprising a gel-forming polysaccharide isolated from psyllium seed husks and an excipient that is fast dissolving in the oral cavity, provide good...
|
|
|
7001612 |
Composition for the relief of heat stress
A composition for the relief of heat stress, particularly for restoration of electrolyte balance due to passive exposure to heat resulting in excessive transpiration/perspiration, without strenuous...
|
|
|
7001611 |
Compositions normalizing circadian rhythm
The present invention provides a circadian rhythm normalizing composition containing astaxanthin and/or its ester as an active ingredient, and a composition having the action of enhancing the...
|
|
|
6998119 |
Feed composition containing Bifidobacterium CNCM 1-2168 capable of preventing diarrhea
The present invention pertains to the use of microorganisms belonging to the genus Bifidobacterium for preparing a carrier for the treatment or prophylaxis of diarrhea. The invention also relates...
|
|
|
6998121 |
Method of treatment of connective tissue disorders by administration of streptolysin O
Method for administering streptolysin O to treat various connective tissue disorders in humans and animals such as Dupuytren's contracture, scleroderma, Peyronie's disease, mastistis in animals,...
|
|
|
6998141 |
Medication combination for hepatoma and pancreatic cancer and preparation protocol
This invention discloses a medication combination, consisting of Baizhu, Danggui, Hanxincao, Huotanmucao, Ainaxiang, Shuodiao, Malan, Ludou, Canger, Daqinggen, Banbianlian, Xingren, Nuzhenzi,...
|
|
|
6998144 |
Method of improving sweetness delivery of sucralose
This invention provides a method of improving the sweetness delivery profile of a sucralose-containing ingestible composition, which comprises incorporating therein DHB at a DHB:sucralose weight...
|
|
|
6994869 |
Nasogastric enteral formulations
The present invention relates to a nasogastric formulation comprising an amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond...
|
|
|
6995166 |
Method and composition for supplementation of nutritional deficiencies in renal patients
The present invention relates to compositions and methods for treating the nutritional deficiencies observed in patients suffering from renal disease and associated disorders. Specifically, the...
|
|
|
RE38958 |
Methods and formulations for control of pests
The subject invention concerns novel biopesticides and their use to control cockroaches, carpenter ants, and pharaoh ants. Specifically, highly virulent isolates of Beauveria bassiana in an...
|
|
|
6989253 |
Biological compositions and methods for treatment of testicular cancer
The present invention relates to pharmaceutical compositions and dietary supplement comprising yeast cells that can produce a healthful benefit in a subject inflicted with testicular cancer. The...
|
|
|
6989161 |
Phytonutrient nutritional supplement
A composition and method for correcting a dietary phytonutrient deficiency. The composition includes one or more of the following phytonutrients: lutein, lycopene, epigallocatechin gallate (EGCG),...
|
|
|
6986908 |
Delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite
The present invention relates to a composition containing a δ-aminolevulinic acid as effective dose for prevention and treatment of infection by pathogenic microorganisms and parasite. More...
|
|
|
6984405 |
Compositions for inducing secretion of insulin-like growth factor-1
The present invention relates to a pharmaceutical or a food composition for inducing or stimulating secretion of insulin-like growth factor-1. More particularly, the present invention relates to...
|
|
|
6982095 |
Capsules containing vital cells or tissues
Capsules which contain vital cells or tissues as the contents and in which these cells or tissues can be grown. Since these cells or tissues can be grown in the capsules, an extremely high cell...
|
|
|
6982256 |
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
The invention relates to new formulations for improving the local tolerance of intravenously administered 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-b
enzoylguanidine or one of the...
|
|
|
6979458 |
Beverage and additive for wellness
The invention is an ingestible wellness one time daily dosage made of a large quantity of rapid absorbing glucosamine sulfate, glucosamine hydrochloride, and an n-acetyl glucosamine and...
|
|
|
6977076 |
Methods for obtaining from Chlorella extract polysaccharides having immunomodulating properties
Chlorella extracts containing high molecular weight Chlorella polysaccharide and polysaccharide complexes show immune modulatory, specifically immune stimulatory, activity. The polysaccharide...
|
|
|
6974594 |
Method of preparing biological materials and preparations produced using same
Methods for preparing products containing moisture-sensitive materials, including biological materials such as proteins, peptides or live cells, comprising at least the steps: (i) providing a...
|
|
|
6974816 |
Combination for the treatment of endothelial damage
The invention relates to a combination of (a) an inhibitor of platelet-derived growth factor (PDGF) activity and (b) a vector for vascular endothelial growth factor (VEGF-, especially VEGF-C) gene...
|
|
|
6974576 |
Chlorella composition having high molecular weight polysaccharides and polysaccharide complexes
Chlorella extracts containing high molecular weight Chlorella polysaccharide and polysaccharide complexes show immune modulatory, specifically immune stimulatory, activity. The polysaccharide...
|
|
|
6964771 |
Method for stably incorporating substances within dry, foamed glass matrices
The invention provides methods for producing foamed glass and the compositions obtained thereby. The compositions are suitable for stable storage of a wide variety of substances, particularly...
|
|
|
6962715 |
Method and dosage form for dispensing a bioactive substance
A method of manufacturing a bioactive fluid dose on an ingestible sheet, comprising the steps of advancing the ingestible sheet to a dispense position, and activating a fluid ejector to dispense...
|
|
|
6958143 |
Chewing gum composition for effectively eliminating nicotine accumulated in a human body
Disclosed is a chewing gum composition capable of eliminating nicotine component from the body of a person chewing the chewing gum. Such a chewing gum composition functions to convert the nicotine...
|
|
|
6956120 |
β-1.3-1.6 glucan (Aureobasidium medium)
Aureobasidium β-1,3-1,6 glucans and compositions containing such glucans, as well as methods of their preparation. Aureobasidium medium that contains β-1,3-1,6 glucans, particularly medium...
|
|
|
6953459 |
Ice dispenser for cold therapy
This invention relates to the field of medical instruments and particularly to an apparatus used to apply cryotherapy to an injury. The apparatus is comprised of a vessel, a driver, and a...
|
|
|
6953574 |
Method for producing a fermented hydrolyzed medium containing microorganisms
A method of producing a hydrolyzed fermented medium containing microorganisms includes providing at least one solid plant product reduced to small pieces and mixed with sugar and biocompatible...
|
|
|
6953592 |
Water soluble powders and tablets
The invention relates to water soluble or water dispersible powders, tablets, or precursors therefor based on a carbohydrate matrix with improved dissolution properties in water. These components...
|
|
|
6949257 |
Pharmaceutical compositions
Spontaneously dispersible pharmaceutical compositions comprising a piperidine, e.g. 1-acylpiperidine Substance P Antagonist and its use in the treatment of CNS disorders, e.g. depression and social...
|
|
|
6946151 |
Therapeutic compositions
An oral composition, suitable as a hypoglycemic agent, includes an isolate from the leaves of Gymnema sylvestre , having a specified molecular weight. The isolate has a molecular weight at least...
|
|
|
6942874 |
Nucleotide compounds that block the bitter taste of oral compositions
Nucleotides that block the bitter taste of foods, beverages, pharmaceutically active oral dose preparations, cosmetics and other bitter compounds that come into contact with taste tissue. The...
|
|
|
6939550 |
Stabilized antihistamine syrup
An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of...
|
|
|
6936262 |
LktA deletion mutant of P. haemolytica
Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be...
|
|
|
6932979 |
Soluble, gum-containing, coated chewable tablet
The soluble, rubber-containing, coated chewable tablet contains chewable components, syrup components and fat or wax components and optionally fillers. It can be prepared by a process in which...
|
|
|
6932980 |
Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
The present invention is to a safe, biodegradable trace metal binding system that effectively delivers chromium, cobalt, copper, iron, manganese, molybdenum, selenium and zinc to animals. The...
|
|
|
6932978 |
Double-headed, closed-mouth cough suppressant and cold relief device
A double-headed, closed-mouth cough suppressant and cold relief device in which an individual having the symptoms of a cough is able to suppress the cough by inserting the device into an open...
|